180 Life Sciences Short ratio
What is the Short ratio of 180 Life Sciences?
The Short ratio of 180 Life Sciences Corp. is 6.78
What is the definition of Short ratio?
Short ratio is the number of shares sold short divided by the average daily volume.
= short interest / average daily volume
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Short ratio of companies in the Health Care sector on NASDAQ compared to 180 Life Sciences
What does 180 Life Sciences do?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Companies with short ratio similar to 180 Life Sciences
- Avid Technology has Short ratio of 6.76
- Greenwich LifeSciences has Short ratio of 6.76
- Aldeyra Therapeutics Inc has Short ratio of 6.76
- Consolidated Communications Inc has Short ratio of 6.77
- Omnicell has Short ratio of 6.77
- Spire has Short ratio of 6.77
- 180 Life Sciences has Short ratio of 6.78
- Independent Bank Inc has Short ratio of 6.79
- Electra Battery Materials Corp has Short ratio of 6.79
- Assembly Biosciences Inc has Short ratio of 6.79
- NanoViricides Inc has Short ratio of 6.79
- Park Hotels & Resorts Inc has Short ratio of 6.79
- Tennant Co has Short ratio of 6.79